Table 1 The characteristic in PCI treatment and matched comparison.
Characters | CHD group (N = 593,088) | CHD-PCI group (N = 296,544) | ASD |
|---|---|---|---|
Year of CHD diagnosed | 0.0020 | ||
<=2014 | 231,958 (39.11%) | 107,314 (36.19%) | |
2015 | 90,531 (15.26%) | 50,769 (17.12%) | |
2016 | 81,382 (13.72%) | 40,669 (13.71%) | |
2017 | 72,154 (12.17%) | 35,991 (12.14%) | |
2018 | 61,843 (10.43%) | 31,349 (10.57%) | |
2019 | 55,220 (9.31%) | 30,452 (10.27%) | |
Index year | 0.0000 | ||
2015 | 117,354 (19.79%) | 58,677 (19.79%) | |
2016 | 109,828 (18.52%) | 54,914 (18.52%) | |
2017 | 108,586 (18.31%) | 54,293 (18.31%) | |
2018 | 103,582 (17.46%) | 51,791 (17.46%) | |
2019 | 105,548 (17.80%) | 52,774 (17.80%) | |
2020 | 48,190 (8.13%) | 24,095 (8.13%) | |
Sex | 0.0000 | ||
Male | 385,830 (65.05%) | 192,915 (65.05%) | |
Female | 207,258 (34.95%) | 103,629 (34.95%) | |
Age | 0.0015 | ||
< 40 | 15,675 (2.64%) | 7697 (2.60%) | |
40–49 | 47,801 (8.06%) | 24,848 (8.38%) | |
50–59 | 115,381 (19.45%) | 57,287 (19.32%) | |
60–69 | 178,844 (30.15%) | 88,300 (29.78%) | |
>=70 | 235,387 (39.69%) | 118,412 (39.93%) | |
Economic level | 0.0021 | ||
Low | 168,830 (28.47%) | 84,413 (28.47%) | |
Low-median | 286,840 (48.36%) | 147,063 (49.59%) | |
Median | 80,882 (13.64%) | 39,630 (13.36%) | |
High | 56,536 (9.53%) | 25,438 (8.58%) | |
Co-morbidity | |||
Hypertension | 387,091 (65.27%) | 223,867 (75.49%) | 0.0525 |
Diabetes mellitus | 179,248 (30.22%) | 125,532 (42.33%) | 0.0637 |
Hyperlipidemia | 252,005 (42.49%) | 174,205 (58.75%) | 0.0821 |
Ischemic stroke | 55,306 (9.33%) | 35,586 (12.00%) | 0.0709 |
Peripheral vascular disease | 16,554 (2.79%) | 10,642 (3.59%) | 0.0842 |
Co-medication | |||
Systemic corticosteroids | 105,171 (17.73%) | 64,822 (21.86%) | 0.0238 |
Aspirin | 224,557 (37.86%) | 178,748 (60.28%) | 0.0965 |
Clopidogrel | 33,739 (5.69%) | 53,143 (17.92%) | 0.1322* |
Direct-acting oral anticoagulants | 14,681 (2.48%) | 12,586 (4.24%) | 0.0847 |
Warfarin | 8388 (1.41%) | 6688 (2.26%) | 0.0799 |
Statin | 213,797 (36.05%) | 143,851 (48.51%) | 0.0318 |
